SCHEMBL21239628

SCHEMBL21239628

CC1=NC(c2ccccc2)=CCO1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.33
RAB9A P51151 6/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.32
HPGD P15428 3/20 0.32
BRD4 O60885 2/20 0.32
BRD2 P25440 1/20 0.32
POLB P06746 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
TDO2 P48775 3/20 0.31
PDE3B Q13370 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15828042 0.68 HSD11B1 (0.36) NPC1RAB9AALDH1A1HPGDL3MBTL1
SCHEMBL22036678 0.64 L3MBTL1 (0.31) L3MBTL1
SCHEMBL677246 0.64 ALDH1A1 (0.33) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL14164164 0.63 CHRNB4 (0.38) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL17327925 0.61 KDM4E (0.36) NPC1RAB9AKDM4EMAPTLMNA
SCHEMBL12599050 0.61 ALDH1A1 (0.33) NPC1RAB9AALDH1A1KMT2ANOTUM
SCHEMBL462826 0.60 L3MBTL1 (0.38) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL27971872 0.59 ALDH1A1 (0.47) NPC1RAB9AKDM4EALDH1A1LMNA
Biphenyl SCHEMBL10535512 0.56 ALDH1A1 (0.60) NPC1RAB9AALDH1A1SMN1; SMN2HPGD
SCHEMBL21151429 0.56 SMN1; SMN2 (0.44) NPC1RAB9AKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968316-B1 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER FORMA THERAPEUTICS INC (US) 2019-08-07 EP disclosed